In the lung, miR-34a is expressed in type II alveolar epithelial cells (AECs) and fibroblasts, and increased miR-34a expression coupled with reduced SIRT1 and SIRT6 expression are associated with IPF and COPD (118–123). Here, SIRT6 is linked to chronic obstructive pulmonary disease.